· 2022–2024 · DOL EFAST2
Search
Browse
Resources
Pricing
EMPRESS THERAPEUTICS, INC — EMPRESS THERAPEUTICS, INC 401(K) PLAN, Form 5500 (2024) | Form 5500 Search
Back to filter
Original filing (PDF)
20250611130848NAL0012238579001
EMPRESS THERAPEUTICS, INC
Form 5500-SF
FILING_RECEIVED
EMPRESS THERAPEUTICS, INC 401(K) PLAN
401(k) retirement plan
Active participants
41
Accounts w/ balance
54
Plan assets (EOY)
$1.8M
Net assets (EOY)
$1.8M
Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
75
Total plan cost
75
Vendor stack
100
Participation health
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for
EMPRESS THERAPEUTICS, INC
.
Find decision makers
Plan sponsor
Name
EMPRESS THERAPEUTICS, INC
EIN
83-1095382
Address
55 CAMBRIDGE PKWY SUITE · CAMBRIDGE, MA · 02142
Phone
(617) 218-1558
Industry
Professional & Technical Services
see all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-06-11
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2S · Automatic enrollment
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Service providers (Schedule C)
Small plans don't disclose service providers
Related plans
Similar-size Professional & Technical Services plans
ENDOVASCULAR ENGINEERING, INC.
ENDOVASCULAR ENGINEERING, INC. 401(K) PLAN
$1.8M · 33 participants
SHANGHAI PHARMA BIOTHERAPEUTICS
SHANGHAI PHARMA BIOTHERAPEUTICS USA INC
$1.8M · 9 participants
XAIRA THERAPEUTICS, INC.
XAIRA THERAPEUTICS, INC. 401(K) PLAN
$1.8M · 111 participants
BETA PHARMA USA, INC.
BETA PHARMA, INC. PROFIT SHARING PLAN
$1.8M · 11 participants
CENTER FOR INNOVATIVE PUBLIC HEALTH RESEARCH, INC.
CIPHR 403(B) PLAN
100
Helping the score
Concentration not scored — Schedule of Assets PDF not yet parsed for this plan.
No Schedule C compensation disclosed — likely a small plan or unbundled.
Audit & trust (Schedule H)
Auditor
—
Trustee / custodian
—
Trustee phone
—
Small plan (5500-SF) — Schedule H data not available.
$1.8M · 15 participants
CLINCON RESEARCH, INC.
CLINCON RESEARCH, INC. 401(K) PLAN
$1.8M · 1 participants
Large plans in Massachusetts
FIDELITY MANAGEMENT TRUST COMPANY
FIDELITY GROWTH COMPANY COMMINGLED POOL
$91.5B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX NON-LENDING SERIES FUND CLASS A
$91.0B
FIDELITY MANAGEMENT TRUST COMPANY
FIDELITY CONTRAFUND COMMINGLED POOL
$59.7B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX SECURITIES LENDING SERIES FUND CLASS I
$53.6B
GEODE CAPITAL MANAGEMENT TRUST COMPANY, LLC
SPARTAN GROUP TRUST FOR EMPLOYEE BENEFIT PLANS SPARTAN 500 INDEX POOL
$47.6B
STATE STREET GLOBAL ADVISORS TRUST COMPANY
STATE STREET S&P 500(R) INDEX SECURITIES LENDING SERIES FUND CLASS II
$46.7B
